Compounds > 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin
Page last updated: 2024-09-03

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and technetium tc 99m pentetate

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin has been researched along with technetium tc 99m pentetate in 1 studies

Compound Research Comparison

Studies
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)		Trials
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)		Recent Studies (post-2010)
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)		Studies
(technetium tc 99m pentetate)		Trials
(technetium tc 99m pentetate)		Recent Studies (post-2010) (technetium tc 99m pentetate)
28003,336275394

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinter, LB; Liversidge, GG; Sternson, WL; Wilson, CG1

Other Studies

1 other study(ies) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and technetium tc 99m pentetate

ArticleYear
Nasal delivery of a vasopressin antagonist in dogs.
    Journal of applied physiology (Bethesda, Md. : 1985), 1988, Volume: 64, Issue:1

    Topics: Administration, Intranasal; Aerosols; Animals; Arginine Vasopressin; Biological Availability; Dogs; Dosage Forms; Female; Injections, Intravenous; Metabolic Clearance Rate; Nasal Cavity; Organometallic Compounds; Pentetic Acid; Technetium Tc 99m Pentetate

1988